SARTORIUS STED BIO And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) – GUILLEMOT (GUI.PA), RANA GRUBER (RANA.OL), OKEA (OKEA.OL) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. GUILLEMOT (GUI.PA)

394.14% Payout Ratio

Guillemot Corporation S.A. engages in the design, manufacture, and sale of interactive entertainment hardware and accessories in France, Germany, the United Kingdom, Spain, the United States, the Netherlands, Canada, Italy, China, Belgium, and Romania. It offers digital hardware, audio equipment, and peripherals under the Hercules brand name; PC and console gaming accessories under the Thrustmaster brand name; and DJ solutions for various connected devices under the DJUCED brand name. The company was founded in 1984 and is based in Carentoir, France.

Earnings Per Share

As for profitability, GUILLEMOT has a trailing twelve months EPS of €-0.03.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.93%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 21%, now sitting on 119.13M for the twelve trailing months.

Volume

Today’s last reported volume for GUILLEMOT is 26050 which is 322.68% above its average volume of 6163.

Moving Average

GUILLEMOT’s worth is way under its 50-day moving average of €5.54 and way below its 200-day moving average of €5.98.

More news about GUILLEMOT.

2. RANA GRUBER (RANA.OL)

87.04% Payout Ratio

Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite that is used for metallurgical applications; magnetite to produce water treatment chemicals; and other special products, such as iron oxide pigments that is used for colorants and developed products under the Colorana brand name. It markets its products to steel manufacturers, water treatment chemical producers, as well as concrete, paint, plastics, heat management, automotive, and toner production industry sectors. The company also exports its products mainly to European customers. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.

Earnings Per Share

As for profitability, RANA GRUBER has a trailing twelve months EPS of kr14.39.

PE Ratio

RANA GRUBER has a trailing twelve months price to earnings ratio of 5.36. Meaning, the purchaser of the share is investing kr5.36 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.43%.

More news about RANA GRUBER.

3. OKEA (OKEA.OL)

63.8% Payout Ratio

OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian Continental Shelf. It holds 44.56% interests in Draugen, 35.2% interests in Brage, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 15% interests in Yme, and 6% interests in Nova. The company was incorporated in 2015 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, OKEA has a trailing twelve months EPS of kr-11.66.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -84.19%.

Moving Average

OKEA’s value is under its 50-day moving average of kr25.57 and way under its 200-day moving average of kr30.58.

More news about OKEA.

4. SARTORIUS STED BIO (DIM.PA)

42.86% Payout Ratio

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Earnings Per Share

As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.

PE Ratio

SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.

More news about SARTORIUS STED BIO.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of €1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

More news about 1.

Leave a Reply

Your email address will not be published. Required fields are marked *